Orai1 Promotes Osteosarcoma Metastasis by Activating the Ras-Rac1-WAVE2 Signaling Pathway

Yunshan Guo1, Jinwen Zhu1, Xiaodong Wang1

  • 1Department of Spinal Surgery, Hong Hui Hospital, Xi'an Jiao Tong University, Xi'an, Shaanxi, China (mainland).

Insights

Orai1 channel silencing significantly reduced osteosarcoma cell migration, invasion, and adhesion. This suggests Orai1 promotes cancer metastasis by activating the Ras-Rac1-WAVE2 pathway.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Osteosarcoma is a primary bone cancer with high metastatic potential.
  • Understanding the molecular mechanisms driving osteosarcoma metastasis is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of Orai1 calcium channel in osteosarcoma metastasis.
  • To elucidate the signaling pathway involved in Orai1-mediated osteosarcoma cell migration and invasion.

Main Methods:

  • Orai1 expression was silenced in MG-63 osteosarcoma cells using Orai1 siRNA.
  • Cell migration, invasion, and adhesion assays were performed.
  • Western blot analysis was used to assess the activity of Ras, Rac1, and WAVE2.
  • Pharmacological inhibitors of Rac1 and Ras were employed to confirm pathway involvement.

Main Results:

  • Silencing Orai1 significantly reduced osteosarcoma cell migration, invasion, and adhesion (p<0.05).
  • Orai1 knockdown inhibited the activity of the Ras-Rac1-WAVE2 signaling pathway.
  • Inhibition of Rac1 or Ras abolished the effect of Orai1 silencing on cell metastasis.

Conclusions:

  • Orai1 promotes osteosarcoma metastasis by activating the Ras-Rac1-WAVE2 signaling pathway.
  • Orai1 may represent a potential therapeutic target for inhibiting osteosarcoma progression.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.1K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.1K